Inamed wrinkle treatments
This article was originally published in The Gray Sheet
Executive Summary
Firm receives supplemental PMA approval for CosmoDerm and CosmoPlast human collagen devices March 12. CosmoDerm is indicated for use in "the superficial papillary dermis for correction of soft tissue contour deficiencies such as wrinkles and acne scars," while CosmoPlast "is injected into the mid to deep dermis for the same results." The approvals are based on an earlier PMA for Zyderm and Zyplast bovine collagen products. The devices, which use Advanced Tissue Sciences' human collagen, require no skin-allergy testing prior to injection. Artes Medical's PMMA/collagen implant may not be far behind following an FDA panel nod last month (1"The Gray Sheet" March 3, 2003, p. 26)...
You may also be interested in...
Artefill PMMA/Collagen Implant Gains Panel Nod With Conditions
Artes Medical should develop patient and physician educational materials for its Artefill PMMA/collagen dermal implant in addition to standard labeling, FDA's General & Plastic Surgery Devices Panel recommends
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.